Fabio Bertozzi
Genoa, 16163, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Molecular targeting of the deubiquitinase USP14 to circumvent cisplatin resistance in ovarian carcinoma and identification of novel inhibitors.
Journal: Cancer drug resistance (Alhambra, Calif.)
Published: April 16, 2025
Target Identification with Live-Cell Photoaffinity Labeling and Mechanism of Action Elucidation of ARN23765, a Highly Potent CFTR Corrector.
Journal: Journal of medicinal chemistry
Published: February 10, 2025
Combined in vivo effect of N-acylethanolamine-hydrolyzing acid amidase and glycogen synthase kinase-3β inhibition to treat multiple sclerosis.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 11, 2024
Oxytocin seals the blood-brain barrier, improving 22q11.2 deletion syndrome trajectories.
Journal: Brain : a journal of neurology
Published: November 10, 2023
Editorial: Protein-Protein Interactions: Drug Discovery for the Future.
Journal: Frontiers in chemistry
Published: November 08, 2021
Discovery and SAR Evolution of Pyrazole Azabicyclo[3.2.1]octane Sulfonamides as a Novel Class of Non-Covalent N-Acylethanolamine-Hydrolyzing Acid Amidase (NAAA) Inhibitors for Oral Administration.
Journal: Journal of medicinal chemistry
Published: September 01, 2021
Inhibition of N-acylethanolamine-hydrolyzing acid amidase reduces T cell infiltration in a mouse model of multiple sclerosis.
Journal: Pharmacological research
Published: June 14, 2021
Partial Rescue of F508del-CFTR Stability and Trafficking Defects by Double Corrector Treatment.
Journal: International journal of molecular sciences
Published: March 11, 2021
Identification, Structure-Activity Relationship, and Biological Characterization of 2,3,4,5-Tetrahydro-1H-pyrido[4,3-b]indoles as a Novel Class of CFTR Potentiators.
Journal: Journal of medicinal chemistry
Published: September 18, 2020
Identification of a 2,4-diaminopyrimidine scaffold targeting Trypanosoma brucei pteridine reductase 1 from the LIBRA compound library screening campaign.
Journal: European journal of medicinal chemistry
Published: August 23, 2019
Discovery of a picomolar potency pharmacological corrector of the mutant CFTR chloride channel.
Journal: Science advances
Published: August 01, 2019
Last Updated: 09/26/2026